Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin: 2016-2024

Historic FCF Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to 0.87%.

  • Organogenesis Holdings' FCF Margin fell 476.00% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.10%, marking a year-over-year decrease of 1196.00%. This contributed to the annual value of 0.87% for FY2024, which is 65.00% down from last year.
  • Organogenesis Holdings' FCF Margin amounted to 0.87% in FY2024, which was down 42.74% from 1.51% recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' FCF Margin ranged from a high of 6.58% in FY2021 and a low of -3.61% during FY2020.
  • Its 3-year average for FCF Margin is 0.12%, with a median of 0.87% in 2024.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 1,153bps in 2020, then slumped by 859bps in 2022.
  • Organogenesis Holdings' FCF Margin (Yearly) stood at -3.61% in 2020, then skyrocketed by 1,019bps to 6.58% in 2021, then crashed by 859bps to -2.00% in 2022, then soared by 352bps to 1.51% in 2023, then slumped by 65bps to 0.87% in 2024.